Diasorin | MeMed
Information
By clicking any links on this page, please note that you will be leaving the SAEM26 Program Planner website/app and going to an external website(s).
Diasorin is a global leader in diagnostic solutions that support timely, evidence‑based care. At SAEM, Diasorin highlights its infection management portfolio, including LIAISON® MeMed BV® and LIAISON BRAHMS PCT®, which provide complementary host‑response biomarkers to help emergency clinicians assess bacterial infection and sepsis risk. Together, these assays support rapid disposition decisions, antimicrobial stewardship, and improved care pathways in the emergency department.